Check here regularly for PLS news, informative industry updates, and announcements from some of our clients.
Upcoming Conferences:
Feb 7-9, 2023 – MD&M West, Anaheim, CA
Feb 15-16, 2023 – Destination Startup, Denver, CO
Visit PLS at MD&M West
Join us Feb 7-9, 2023 for MD&M West in Anaheim, CA. We’ll be in Booth 1347 and look forward to seeing you.
Spinal Stabilization Technologies in LOPAIN2 Trial
Congratulations to Spinal Stabilization Technologies on beginning their LOPAIN2 clinical trial, measuring the efficacy of the PerQdisc Nucleus Replacement Device (NRD).
Allotrope Medical, Inc. Earns FDA Safer Technologies Program (STeP) Designation
Congratulations to Allotrope Medical Inc. on receiving a Safer Technologies Program (STeP) designation for their StemSite surgical device. Inclusion in STeP indicates that this medical device is expected to significantly improve the safety of currently available treatments. Read the full story to learn more.
PLS Attends MPO Summit 2022
We had a great time at the MPO Summit in Austin, TX. It is always a treat to spend quality time networking, learning, and forging new relationships with med device entrepreneurs and innovators.
PLS Attends Rocky Mountain Life Sciences Investor and Partnering Conference
What’s better than spending a couple of days in Vail, CO? Being there as part of Colorado BioScience Association’s partnering conference. The caliber of talent was impressive and we were happy to be able to share our medical device manufacturing expertise and capabilities with some of the industry’s emerging entrepreneurs.
LUCI Announces Partnership with NREL
In partnership with the U.S. Department of Energy’s National Renewal Energy Laboratory (NREL), LUCI announced they will working to create better alternatives to airport walkways.
Visit PLS at MD&M West, April 12-14, 2022
Prospect is excited to be exhibiting at MD&M West again this year. Come see us in Booth #3278.
Paragon28 Receives FDA Approval for Patient Specific Titanium Talus Spacer
Congratulations to Paragon28 on having their Patient Specific Titanium Talus Spacer approved by the FDA. Read the full press release for details.
Visit us at CBSA’s Innovation Forward
We are excited to be both attending and exhibiting at Colorado BioScience Association’s Innovation Forward: Forum + Awards Celebration Tuesday October 12, 2021. Come see us in Booth 16!
SST Earns CE Mark and FDA “Breakthrough Designation”
Congratulations to Spinal Stabilization Technologies, LLC (SST) on earning the CE mark and the FDA’s “breakthrough designation” for its PerQdisc™ Nucleus Replacement System. Read the full press release here.